Today: 22 June 2026
Browse Category

Stock Market 11 December 2025

Cognizant Technology Solutions fell 10.49% to $43.70 after Accenture warned of weaker IT-services demand and Berenberg downgraded the stock, erasing about $2.4 billion in equity value. Campbell’s Company edged up 0.19% to $21.15, but S&P Dow Jones Indices will remove it from the S&P 500 and add it to the S&P SmallCap 600. Infosys dropped 6.75% to ₹1,051.40 as Accenture cut its fiscal 2026 revenue growth forecast to 3%-4%, which also pressured TCS and HCLTech. Six Fiserv executives and board members bought 34,781 shares for $1.72 million at an average of $49.55, but Fiserv shares closed at $47.86, down 3.4%. CoreWeave will join the Nasdaq-100, with shares up 2.38% Thursday and 17.3% over five days. SpaceX fell 3.56% to $185.00, with options pricing in a ±10% weekly move, while Micron hit a record $1,133.99, up 8.7%. Verizon closed at $45.37, down 5.7% for the week, as new plans and fee cuts focus on subscriber growth. Plug Power rose 7.55% to $2.85, with the coming week focused on cash and financing. Nu finished at $12.71, down 1.4% Thursday but up 4.3% for the week, with a $1 billion buyback in focus. U.S. markets were closed Friday for Juneteenth. Transocean ended at $5.31, down from $6.04. Super Micro rose 10.37% to $30.66, with attention on a $7 billion equity-linked deal. GE Vernova, Vertiv, and Eaton posted strong gains, while regulators gave grid operators 60 days to review rules for large electricity users. Bank of America closed at $56.20, with stress-test results due Wednesday. Amazon gained 2.9% to $244.39 ahead of Prime Day. Flex will join the S&P 500, last closing at $147.61. SoFi rose 2.8% to $17.91, up 8% for the week. AMC ended at $2.83, up 21% from the prior Friday.
Immunovant (IMVT) Stock Jumps After $550 Million Share Offering as Graves’ Disease Launch Comes Into Focus

Immunovant (IMVT) Stock Jumps After $550 Million Share Offering as Graves’ Disease Launch Comes Into Focus

Immunovant shares rose 9% to $25.75 Thursday after the company announced a $550 million common stock offering to fund development and possible launch of its lead drug, IMVT‑1402, for Graves’ disease. The offering priced at $21 per share, an 11% discount, and is expected to close December 12. Roivant Sciences will participate. Immunovant’s market value reached about $4 billion.
AbbVie Stock (ABBV): HSBC Upgrade, Dividend Hike and New FDA Win Reshape the 2025 Outlook

AbbVie Stock (ABBV): HSBC Upgrade, Dividend Hike and New FDA Win Reshape the 2025 Outlook

AbbVie shares rebounded 2.98% to $236.28 on Nov. 21, 2025, with trading volume spiking to 7.9 million after three down days. Year-to-date, the stock is up about 22–26%, outpacing the S&P 500, but remains 7–9% below its October high. Forward P/E estimates range from 16x to 22x. Investors weigh strong Skyrizi and Rinvoq sales against Humira declines and regulatory risk.
Coeur Mining (CDE) Stock on December 11, 2025: Palmarejo Breakthroughs, $7B New Gold Deal and What Comes Next

Coeur Mining (CDE) Stock on December 11, 2025: Palmarejo Breakthroughs, $7B New Gold Deal and What Comes Next

Coeur Mining shares traded around $16.84 on December 11, up 5% intraday, with volume over 6 million. The company announced a $7 billion all-stock deal to acquire New Gold Inc. and posted record Q3 revenue of $555 million and net income of $267 million. CDE’s market value has surged to about $10 billion after a rally from a 52-week low of $4.58 to a high near $23.61.
Snowflake (SNOW) Stock Outlook After November 21, 2025: AI Deals, Legal Risks and Price Targets to 2030

Snowflake (SNOW) Stock Outlook After November 21, 2025: AI Deals, Legal Risks and Price Targets to 2030

Snowflake shares have fallen to around $218, down 7% since November 21 and 22% below their November 3 high. The stock dropped sharply after Q3 FY26 earnings on December 3, when strong growth was offset by weaker margin guidance. Shares remain over 50% higher year-to-date. Wall Street analysts have since raised price targets despite the recent slide.
Linde Stock (LIN) Outlook for 2026: What 52‑Week Lows, Insider Buying and New Debt Deals Signal for Investors

Linde Stock (LIN) Outlook for 2026: What 52‑Week Lows, Insider Buying and New Debt Deals Signal for Investors

Linde shares hit a 52-week low of $387.78 in late November 2025, trading at $398.9 on December 11, below key moving averages. CEO insider buying and new analyst calls followed, along with multiple debt and credit moves. Q3 adjusted EPS rose to $4.21 on $8.6 billion revenue, but weak European volumes and cautious Q4 guidance pressured the stock. Market cap stands at about $186 billion.
11 December 2025
Belite Bio (NASDAQ: BLTE) Stock: DRAGON Trial Breakthrough, $350 Million Offering and Outlook After a 130% Rally

Belite Bio (NASDAQ: BLTE) Stock: DRAGON Trial Breakthrough, $350 Million Offering and Outlook After a 130% Rally

Belite Bio shares climbed to $154 on December 11, 2025, up over 130% year-to-date, after announcing positive Phase 3 results for tinlarebant in Stargardt disease. The company’s market value reached $5–6 billion. The DRAGON trial showed tinlarebant cut lesion growth by 36% versus placebo in adolescents with STGD1. Wall Street analysts project further upside for the stock.
11 December 2025
Wayfair (W) Stock Nears $100 as Hedge Funds Buy and Jefferies Turns Cautious – December 11, 2025 Outlook & Forecast

Wayfair (W) Stock Nears $100 as Hedge Funds Buy and Jefferies Turns Cautious – December 11, 2025 Outlook & Forecast

Wayfair shares rose about 7% Thursday to near $100, following a volatile year that saw the stock rally over 100% year to date but fall 17% in the past month. The stock remains nearly 19% below its November high. Hedge funds, including Mane Global Capital, disclosed new stakes, while short interest hovers near 15%. Insiders have been selling as analysts remain split on the outlook.
Wells Fargo Stock (WFC) Near Record Highs: Latest News, AI Job Cuts, Buybacks and 2026 Forecast

Wells Fargo Stock (WFC) Near Record Highs: Latest News, AI Job Cuts, Buybacks and 2026 Forecast

Wells Fargo stock closed at $90.68 on December 10, 2025, near its 52-week high, after the Federal Reserve lifted its asset cap in June and the bank announced a $40 billion share buyback. Shares have gained over 26% year-to-date, outpacing peers. Technical models now rate WFC a “Strong Buy” for the next three months. Regulatory scrutiny and legal settlements remain ongoing.
Upwork (UPWK) Stock Hits Fresh 52‑Week High: AI Partnerships, Index Inclusion and Q3 Earnings Rewire the 2026 Outlook

Upwork (UPWK) Stock Hits Fresh 52‑Week High: AI Partnerships, Index Inclusion and Q3 Earnings Rewire the 2026 Outlook

Upwork shares hit a new 52-week high of $21.39 on December 11, 2025, lifting its market cap to about $2.46 billion. The stock is up nearly 90% from its yearly low, driven by record Q3 results, new AI partnerships, and entry into the S&P SmallCap 600. Insider selling and high short interest remain. Upwork now posts positive GAAP earnings and a gross margin near 78%.
Marvell Technology (MRVL) Stock: AI Infrastructure Star Faces Fresh Amazon and Microsoft Risks After November Rally

Marvell Technology (MRVL) Stock: AI Infrastructure Star Faces Fresh Amazon and Microsoft Risks After November Rally

Marvell Technology shares rose about 17% to $90–91 as of December 11, 2025, after reporting record earnings and announcing a multi-billion-dollar AI acquisition. The stock had closed at $77.45 on November 21, before spiking near $100 and then retreating on concerns over business with Amazon and Microsoft. Institutional investors increased holdings, while insiders bought shares around $78. Trading volume and volatility surged.
Coca-Cola (KO) Stock Outlook December 2025: New CEO, Dividend Power and Analyst Forecasts

Coca-Cola (KO) Stock Outlook December 2025: New CEO, Dividend Power and Analyst Forecasts

Coca-Cola shares traded around $69–70 intraday on December 11, 2025, down from late-November highs above $73 but well above the 52-week low. The board named Henrique Braun as CEO effective March 31, 2026, with James Quincey moving to Executive Chairman. KO delivered an estimated 11.9% one-year return, lagging the S&P 500 but outperforming its industry.
Lumentum Holdings (LITE) Stock Soars Above $360 on AI Optics Boom: Price Targets, Valuation and 2026–2028 Forecasts After the November Rally

Lumentum Holdings (LITE) Stock Soars Above $360 on AI Optics Boom: Price Targets, Valuation and 2026–2028 Forecasts After the November Rally

Lumentum shares surged to $366 on December 11, 2025, after hitting a record $300.20 on November 26. The stock is up nearly 290% year-to-date, driven by soaring demand for AI datacenter optics and cloud networking. Fiscal 2025 revenue rose 21% to $1.65 billion, and the company swung to a $25.9 million profit from a $546.5 million loss. Over 60% of recent revenue is tied to AI and cloud infrastructure.
11 December 2025
Brinker International (EAT) Stock: Fresh News, Analyst Forecasts and Turnaround Outlook as of December 11, 2025

Brinker International (EAT) Stock: Fresh News, Analyst Forecasts and Turnaround Outlook as of December 11, 2025

Brinker International shares rose 7% to $146 intraday on December 11, 2025, after outperforming short-term trading models and drawing institutional interest. The stock remains 24% below its 52-week high and 46% above its low. Chili’s same-store sales have grown by high teens to low 20% in recent quarters, driving improved margins and over $500 million in debt reduction.
Home Depot (HD) Stock Outlook: Q3 2025 Earnings, 2026 Guidance and Wall Street Forecasts After the November Slide

Home Depot (HD) Stock Outlook: Q3 2025 Earnings, 2026 Guidance and Wall Street Forecasts After the November Slide

Home Depot shares traded near $361 on December 11, about 16% below their 52-week high of $428. The stock is down roughly 10% year-to-date, lagging the S&P 500’s 16% gain. Q3 net sales rose 2.8% to $41.4 billion, but net earnings were flat and EPS slipped. Management cited weak housing and consumer demand as ongoing challenges.
Lemonade (LMND) Stock Soars to 52-Week High on Tesla Integration and Q3 2025 Beat: Is the Rally Sustainable?

Lemonade (LMND) Stock Soars to 52-Week High on Tesla Integration and Q3 2025 Beat: Is the Rally Sustainable?

Lemonade shares traded near $82 on December 11, 2025, after hitting a 52-week high above $84.50, up from a low near $24. The company’s market cap has more than doubled to about $6 billion in the past year. Lemonade’s price-to-sales ratio stands near 9x, far above traditional insurers. Q3 revenue rose 42% year-over-year to about $195 million.
Broadcom (AVGO) Stock on December 11, 2025: AI Giant Faces Earnings Test, VMware Scrutiny and Sky‑High Expectations

Broadcom (AVGO) Stock on December 11, 2025: AI Giant Faces Earnings Test, VMware Scrutiny and Sky‑High Expectations

Broadcom shares traded near record highs at $399 on December 11, 2025, ahead of its Q4 earnings report. The company expects Q4 revenue of $17.4 billion, up 24% year-over-year, with AI chip sales driving growth. Options markets are pricing in a possible 6% swing after results. Broadcom faces new regulatory scrutiny in Europe.
Rocket Lab (RKLB) Stock in 2025: Q3 Earnings, Neutron Milestones and Analyst Forecasts After the November 21 Sell‑Off

Rocket Lab (RKLB) Stock in 2025: Q3 Earnings, Neutron Milestones and Analyst Forecasts After the November 21 Sell‑Off

Rocket Lab stock plunged 40% into November 21, 2025, then rebounded as new Neutron rocket milestones and government funding were announced. Q3 revenue hit a record $155 million, up 48% year-over-year, while net loss narrowed to $18 million. The company’s valuation remains steep, with a price-to-sales ratio near 38x and ongoing losses. Analyst forecasts expect continued high growth but warn of risks.
Rhythm Pharmaceuticals (RYTM) Hits Record High on Rare-Disease Breakthrough: Latest News, Stock Forecast and Analyst Outlook

Rhythm Pharmaceuticals (RYTM) Hits Record High on Rare-Disease Breakthrough: Latest News, Stock Forecast and Analyst Outlook

Rhythm Pharmaceuticals shares jumped over 15% to a record high near $121 on December 11 after reporting positive interim Phase 2 data for setmelanotide in Prader-Willi syndrome. Six of eight patients showed BMI reductions at three months, and most saw declines in hunger scores. The company plans a Phase 3 trial pending Phase 2 completion. RYTM stock is up around 80–90% year-to-date.
11 December 2025

Stock Market Today

  • SpaceX Makes History with Largest IPO Ever, Raising $75 Billion
    June 21, 2026, 11:04 PM EDT. SpaceX marks a pivotal moment in markets with its IPO, aiming to raise a record $75 billion, three times larger than Saudi Aramco's 2019 debut. The company is offering under 10% of its shares, allowing early investors and venture capitalists an exit and opening opportunities for retail investors. This historic public listing comes amid a surge of mega IPOs, including OpenAI, Anthropic, and SK Hynix, pointing to a wave of trillion-dollar valuations entering U.S. markets. Investment experts Travis Hoium, Lou Whiteman, and Jon Quast from Motley Fool highlight this as a potentially transformative moment for public investing and space industry stakeholders.

Latest articles

Cognizant (NASDAQ: CTSH) Slides 10% as Nasdaq-100 Exit Nears

Cognizant (NASDAQ: CTSH) Slides 10% as Nasdaq-100 Exit Nears

22 June 2026
Cognizant shares plunged 10.49% to $43.70, erasing $2.4 billion in equity value—more than its $2 billion 2026 buyback target—after Accenture’s narrowed growth outlook, a Berenberg downgrade, and looming Nasdaq-100 removal, even as S&P 500 and Nasdaq rallied; investors now eye Q2 guidance as the next key test.
Pentagon Could Outpace Tech Giants on Small Nuclear Projects

Pentagon Could Outpace Tech Giants on Small Nuclear Projects

22 June 2026
Valar Atomics’ Ward 250 became the first DOE-authorized advanced reactor built outside a national lab to achieve criticality, signaling a shift as U.S. defense demand accelerates small nuclear deployment, with the Army allocating over $2 billion for microreactors—moving the sector from policy to production and raising near-term demand expectations.
Go toTop